MMJ International Holdings Files FDA Orphan Drug Application for Huntington's Disease

By finanzen
2018.11.09. 19:50
4
(Vote: 0)

RESTON, Va., Nov. 9, 2018 /PRNewswire-PRWeb/ -- MMJ International Holdings, the premier medical cannabis research company, announced that is has filed an application with the FDA for "Orphan Drug Designation" for its drug which will be used for the treatment...



finanzen - MMJ International Holdings Files FDA Orphan Drug Application for Huntington's Disease
Ältere artikel
  • Neu in der letzten 40 Minuten

  • PORT MORESBY, Papua New Guinea, Nov. 19, 2018 /PRNewswire/ -- During the APEC CEO Summit 2018 from November 15th to 17th, the APEC LSIF Rare Disease Network announced the official launch of a Rare Disease Action...
    Tiefe Gräben zwischen China und den USA - Neue Zürcher Zeitung 
    Representatives react to Chinese President's call for openness and cooperation at APEC CEO Summit 
    Streit mit China auf Apec-Gipfel: USA ringen um Einfluss im Pazifikraum 

    Ältere Nachrichten
    WARREN, N.J., Nov. 16, 2018 /PRNewswire/ -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) today announced it received a complete response letter (CRL) from the U.S. Food and Drug Administration (FDA) in regards to its New Drug Application (NDA) for tadalafil...
    Bridge Biotherapeutics Files Investigational New Drug Application for BBT-877, an Autotaxin Inhibitor for Idiopathic Pulmonary Fibrosis 
    Landmark PALISADE Trial of AR101 Published in New England Journal of Medicine 
    Sehenswert: 5 Food-Serien, bei denen ihr etwas lernen könnt 

    Novartis International AG / FDA approves Novartis drug Promacta(R) for first-line SAA and grants Breakthrough Therapy designation for additional new indication. Processed and transmitted by West Corporation. The issuer is solely responsible for the content of this announcement. -- Promacta receives FDA...
    Bridge Biotherapeutics Files Investigational New Drug Application for BBT-877, an Autotaxin Inhibitor for Idiopathic Pulmonary Fibrosis 
    Toynk Toys' Highly Anticipated Fallout Product Line & Release Dates 
    Novartis: la FDA homologation et percée thérapeutique pour Promacta 

    DGAP-Ad-hoc: PAION AG / Key word(s): Research UpdatePAION ANNOUNCES THAT NMPA ACCEPTS SUBMISSION OF NEW DRUG APPLICATION FOR REMIMAZOLAM BY CHINESE LICENSEE YICHANG HUMANWELL 16-Nov-2018 / 10:45 CET/CESTDisclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No...
    Bridge Biotherapeutics Files Investigational New Drug Application for BBT-877, an Autotaxin Inhibitor for Idiopathic Pulmonary Fibrosis 
    DGAP-Adhoc: Dermapharm Holding SE: Vertragsunterzeichnung zur Übernahme der EUROMED S.A. 
    DGAP-Adhoc: Dermapharm Holding SE: Signing of contract for the acquisition of EUROMED S.A. 

    DENVER, Nov. 15, 2018 /PRNewswire/ -- M.D.C. Holdings, Inc. (NYSE: MDC), has posted a recording of its Investor Day Webcast from their event last Thursday, November 8. During this webcast, investors learned about the company's...
    Italien: Gubitosi wird neuer Chef von Telecom Italia – Sieg für Investor Elliott 
    Press release: ABN AMRO hosts 'Banking for Better' Investor Day 
    ServiceMaster Announces Details for Investor Day 

    Create Account



    Log In Your Account